Daraxonrasib, a pancreatic cancer drug from Revolution Medicines, is showing unprecedented success. For patients like Leanna ...

From billionaire-backed biotech to promising animal studies, this early trial will test whether partial reprogramming can ...

Detroit patients getting HEMGENIX report life‑changing results; trial data show 94% off prophylaxis at five years.

A rare condition that's been around since the 1950s now has a modern treatment creating a promising future for those who've ...

The firm also said this week that the NCCN added the HER2xHER3 bispecific antibody to its biliary tract cancer treatment guidelines.

Mayo Clinic scientists are exploring an unusual but promising strategy to treat one of the deadliest bile duct cancers by turning milk into a microscopic delivery system for gene therapy. Their work ...

Researchers from The University of Texas MD Anderson Cancer Center will present initial data from six clinical trials during minisymposia at this week’s American Association for Cancer Research (AACR) ...

Cancer drugs are designed to shut tumors down. But sometimes, in the very act of attacking a tumor, treatment can also help a small fraction of cancer cells become harder to kill. A new study from ...

A long-standing mystery in cancer treatment is how tumor cells so often become resistant to drugs, even ones they have never encountered before.

A lab in Hawaiʻi is developing nanobodies, tiny proteins that help the immune system recognize and destroy cancer cells, ...

An international group led by researchers from the RIKEN Center for Integrative Medical Sciences (IMS) in Japan has ...

This important paper substantially advances our understanding of how Molidustat may work, beyond its canonical role, by identifying its therapeutic targets in cancer. This study presents a compelling ...